Caribou Biosciences (CRBU) FCF Margin (2020 - 2026)

Caribou Biosciences (CRBU) has 7 years of FCF Margin data on file, last reported at 1126.41% in Q1 2026.

• FCF Margin for Q1 2026 came in at 1126.41%, up 43925.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 915.1% (up 47368.0% YoY), and the FY2025 annual result was 1006.89%, up 38348.0% from the prior year.
• FCF Margin eased to 1126.41% in Q1 2026 per CRBU's latest filing, from 523.12% in the prior quarter.
• Over five years, FCF Margin peaked at 104.64% in Q3 2023 and troughed at 1726.1% in Q4 2024.
• A 5-year average of 947.45% and a median of 850.38% in 2022 frame the typical range for FCF Margin.
• The sharpest annual moves came in 2022 and 2025: FCF Margin tumbled 212976 bps in 2022, then soared 120298 bps in 2025.
• A 5-year view of FCF Margin shows it stood at 584.24% in 2022, then slipped by 4 bps to 604.69% in 2023, then sank by 185 bps to 1726.1% in 2024, then surged by 70 bps to 523.12% in 2025, then slumped by 115 bps to 1126.41% in 2026.
• Business Quant data shows CRBU's FCF Margin at 1126.41% in Q1 2026, 523.12% in Q4 2025, and 1151.05% in Q3 2025.